![Zai Lab Limited logo](/logos/9688.HK.webp)
Zai Lab Limited
HKEX:9688.HK
Overview | Financials
Company Name | Zai Lab Limited |
Symbol | 9688.HK |
Currency | HKD |
Price | 15.68 |
Market Cap | 15,541,636,544 |
Dividend Yield | 0% |
52-week-range | 10.56 - 24.4 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ying Du Ph.D. |
Website | https://www.zailaboratory.com |
An error occurred while fetching data.
About Zai Lab Limited
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA for acute bacterial skin and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD